Marcelo Garrido

1998–2025 年に発表

76: 論文数
25,508: 被引用数
38: h 指数
66: i10 指数

被引用数

引用元

国・地域

0%19.4%その他 24.8%

機関

分野

トピック

全論文

並び替え

検索で開く

First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial
著者: Yelena Y. Janjigian, Kohei Shitara, Markus Moehler, Marcelo Garrido, Pamela Salman, Lin Shen, Lucjan Wyrwicz, Kensei Yamaguchi, Tomasz Skoczylas, Arinilda Campos Bragagnoli, Tianshu Liu, Michael Schenker, Patricio Yañez, Mustapha Tehfé, Rubén Dario Kowalyszyn, Michalis V. Karamouzis, Ricardo Brugés, Thomas Zander, Roberto Pazo-Cid, Erika Hitre, Kynan Feeney, James M. Cleary, Valerie Poulart, Dana Cullen, Ming Lei, Hong Xiao, Kaoru Kondo, Mingshun Li, Jaffer A. Ajani - The Lancet 2021 被引用: 2,927
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
著者: Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais, Rafael Díaz, Mark Lakshmanan, Prem Pais, Jeffrey L. Probstfield, Jeffrey S. Riesmeyer, Matthew C. Riddle, Lars Rydén, Denis Xavier, Charles Atisso, Leanne Dyal, Stephanie Hall, Rao Ps, G.C. Wong, Álvaro Avezum, Jan Basile, Namsik Chung, Ignacio Conget, William C. Cushman, Edward Franek, Nicolae Hâncu, M Hanefeld, Shaun Holt, Petr Janský, Mátyás Keltai, Fernando Laņas, Lawrence A. Leiter, Patricio López‐Jaramillo, Ernesto Muñoz, Valdis Pīrāgs, Nana Pogosova, Peter Raubenheimer, Jonathan E. Shaw, Wayne Huey‐Herng Sheu, Theodora Temelkova‐Kurktschiev, Mercedes Abella, Andrea Alebuena, Sandra Almagro, Eduardo Amoroso, Paula Anadon, Elizabeth Andreu, Guillermo Aristimuño, Maria Arzadun, María Antonietta Barbieri, Raúl Barcudi, Ines Bartolacci, Gabriel Bolobanich, Anselmo P. Bordonava, Miguel Bustamante Labarta, B. Bustos, Alberto Caccavo, Alejandra Camino, María del Rocío Cantero, Maria Carignano, Luis R Cartasegna, Marcela Cipullo, Víctor Commendatore, Victoria Conosciuto, Osvaldo Costamagna, Claudia A. Crespo, Jose Cuello, Carlos Alberto Cuneo, Sandra Cusimano, Sofia Dean, Claudio Fabián Dituro, Andrea Domínguez, Miguel Farah, Alberto Fernandez, Florencia Fernandez, Adriana Cristina Ferrari, Patricia Flammia, José Antonio Fuentealba, Karina Beatriz Gallardo, C. Perez Garcia, Ruben Garcia Duran, Marcelo Garrido, Rodolfo Gavícola, Claudio Gerbaudo, Graciela Gilli, Ana Paula Giotto, Pedro Godoy Bolzán, Oscar Gómez Vilamajó, Fernando Guerlloy, Cristian Guridi, Narcisa Gutierrez Garrido, Eduardo Hasbani, Sonia Hermida, Miguel Hominal, Adrian D. Hrabar, Adrián Ingaramo, Alejandra Izzicupo, Mario Krynski, Mariana Lagrutta, Paulina Virginia Lanchiotti, Maria Langhe, Veronica Leonard, Javier Llanos, Ricardo López Santi ほか 1,358 名 - The Lancet 2019 被引用: 3,040
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
著者: Roy S. Herbst, Paul Baas, Dong‐Wan Kim, Enriqueta Felip, José Luis Perez‐Gracia, Ji‐Youn Han, Julian R. Molina, Joo-Hang Kim, Catherine Dubos Arvis, Myung‐Ju Ahn, Margarita Majem, Mary J. Fidler, Gilberto de Castro, Marcelo Garrido, Gregory M. Lubiniecki, Yue Shentu, Ellie Im, Marisa Dolled‐Filhart, Edward B. Garon - The Lancet 2015 被引用: 6,537
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
著者: Richard S. Finn, Baek‐Yeol Ryoo, Philippe Merle, Masatoshi Kudo, Mohamed Bouattour, Ho Yeong Lim, В. В. Бредер, Julien Edeline, Yee Chao, Sadahisa Ogasawara, Thomas Yau, Marcelo Garrido, Stephen L. Chan, Jennifer J. Knox, Bruno Daniele, Scot Ebbinghaus, Erluo Chen, Abby B. Siegel, Andrew X. Zhu, Ann‐Lii Cheng, on behalf of the KEYNOTE-240 investigators - Journal of Clinical Oncology 2019 被引用: 1,819
Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer
著者: Kohei Shitara, Eric Van Cutsem, Yung‐Jue Bang, Charles S. Fuchs, Lucjan Wyrwicz, Keun‐Wook Lee, Iveta Kudaba, Marcelo Garrido, Hyun Cheol Chung, Jeeyun Lee, Hugo R. Castro, Wasat Mansoor, Maria Ignez Braghiroli, Nina Karaseva, Christian Caglevic, Luis J. Villanueva-Rivera, Eray Goekkurt, Hironaga Satake, Peter C. Enzinger, María Alsina, Al B. Benson, Joseph Chao, Andrew H. Ko, Zev A. Wainberg, Uma Kher, Sukrut Shah, Soonmo Peter Kang, Josep Tabernero - JAMA Oncology 2020 被引用: 1,125
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
著者: Sun Young Rha, Do‐Youn Oh, Patricio Yañez, Yuxian Bai, Min‐Hee Ryu, Jeeyun Lee, Fernando Rivera, Gustavo Vasconcelos Alves, Marcelo Garrido, Kai‐Keen Shiu, M. Fernández, Jin Li, Maeve A. Lowery, Timuçin Çil, Felipe Melo Cruz, Shukui Qin, Suxia Luo, Hongming Pan, Zev A. Wainberg, Lina Yin, Sonal Bordia, Pooja Bhagia, Lucjan Wyrwicz, Guillermo Méndez, Juan Manuel O’Connor, Alvaro Yanzi Castilla, Juan Cundom, Diego Kaen, Rachel Wong, Weng Ng, Morteza Aghmesheh, Mauricio Peressoni, Carlos Eduardo Mattos da Cunha Andrade, Fábio Franke, Gustavo R. Alves, Felipe Jose Cruz, Karina Vianna, Maria Marcela Monteiro, Michael J. Raphael, Scott Berry, Raymond Woo-Jun Jang, Ann Tan, Jamil Asselah, Patricio Yañez Weber, Mauricio Mahave, César Sánchez, Pamela Salman, Yuxian Bai, Jin Li, Xiaochun Zhang, Tianshu Liu, Xiaoyan Lin, Shukui Qin, Jianwei Yang, Suxia Luo, Wěi Li, Jieer Ying, Xi Chen, Shan Zeng, Yanli Qu, Lin Yang, Lin Zhao, Ping Chen, Hongming Pan, Enxiao Li, Feng Ye, Jianwei Lu, Xinjun Liang, Qun Zhao, Xianli Yin, Junhe Li, Junhe Li, Guoqing Lv, Shouguo Li, Álvaro Guerrero, Juan Rubiano, M. Fernández, Ray Manneh Kopp, Adrián Guzmán Ramírez, Luis Corrales, Ileana Gonzalez Herrera, Bohuslav Melichar, Tomáš Büchler, Tomáš Svoboda, Radka Obermannová, David Vrána, Jakub Cvek, Per Pfeiffer, Lene Bæksgaard, Mette Yilmaz, Valérie Boige, Daniel López‐Trabada, Christophe Borg, Diane Pannier, Sandrine Hiret, Frédéric Di Fiore, Jean‐Philippe Metges, Dirk Arnold, Uwe M. Martens, Florian Lordick ほか 128 名 - The Lancet Oncology 2023 被引用: 622
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer
著者: Charles S. Fuchs, Toshihiko Doi, Raymond Woo-Jun Jang, Kei Muro, Taroh Satoh, Manuela Machado, Weijing Sun, Shadia I. Jalal, Manish A. Shah, Jean-Phillipe Metges, Marcelo Garrido, Talia Golan, Mario Mandalà, Zev A. Wainberg, Daniel V.T. Catenacci, Atsushi Ohtsu, Kohei Shitara, Ravit Geva, Jonathan Bleeker, Andrew H. Ko, Geoffrey Y. Ku, Philip Philip, Peter C. Enzinger, Yung‐Jue Bang, Diane Levitan, Jiangdian Wang, Minori Koshiji Rosales, Rita P. Dalal, Harry H. Yoon - JAMA Oncology 2018 被引用: 1,812
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
著者: Josep M. Llovet, Masatoshi Kudo, Philippe Merle, Tim Meyer, Shukui Qin, Masafumi Ikeda, Ruocai Xu, Julien Edeline, Baek‐Yeol Ryoo, Zhenggang Ren, Gianluca Masi, Mariusz Kwiatkowski, Ho Yeong Lim, Jee Hyun Kim, В. В. Бредер, Hiromitsu Kumada, Ann‐Lii Cheng, Peter R. Galle, Shuichi Kaneko, Anran Wang, Kalgi Mody, Corina E. Dutcus, Leonid Dubrovsky, Abby B. Siegel, Richard S. Finn, Simone I. Strasser, Alexander Thompson, Aflah Roohullah, William Sievert, Vladimir Andelkovic, Jennifer J. Knox, Janine M. Davies, Jamil Asselah, Mayur Brahmania, Habeeb Majeed, Luis J. Villanueva-Rivera, Patricio Yañez Weber, Marcelo Garrido, Gonzalo Pizarro, Nicolás Yáñez, Ruocai Xu, Shuangyan Ou, Zhenggang Ren, Hongming Pan, Zhiqiang Meng, Kangsheng Gu, Xi Chen, Tao Zhang, Chunyi Hao, Peiguo Cao, Yabing Guo, Shukui Qin, Juxiang Xiao, Weijia Fang, Xin Wang, Yuxian Bai, Xiaoming Chen, Dong Yan, Hong Zhao, Jieer Ying, Carlos Bonilla, Olga Urrego, Ángela R. Zambrano, Mauricio Lema, Juan Carlos Restrepo, Andrés F. Cardona, Sandra Franco Millan, Madiedo Oscar, Víctor Ramos, Philippe Merle, Samuel Lesourd, Julien Edeline, Jean–Pierre Bronowicki, Marc Bourlière, Stéphane Cattan, Mohamed Bouattour, Laurent Mineur, Hélène Regnault, Barbara Dauvois, Kornelius Schulze, Gunnar Folprecht, Andreas Geier, Oliver Waidmann, Fabian Finkelmeier, Marino Venerito, Marie‐Luise Berres, Thomas Berg, Christian M. Lange, Hartmut Schmidt, Dirk Waldschmidt, Michael Bitzer, Ray McDermott, Austin G. Duffy, Gianluca Masi, Vittorina Zagonel, Giuseppe Tonini, Fabio Piscaglia, Stefania Gori, Mimma Rizzo, Elisa Biscaldi ほか 109 名 - The Lancet Oncology 2023 被引用: 421
Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer
著者: Kohei Shitara, Jaffer A. Ajani, Markus Moehler, Marcelo Garrido, Carlos Gallardo, Lin Shen, Kensei Yamaguchi, Lucjan Wyrwicz, Tomasz Skoczylas, Arinilda Campos Bragagnoli, Tianshu Liu, Mustapha Tehfé, Elena Elimova, Ricardo Brugés, Thomas Zander, Sérgio de Azevedo, Rubén Dario Kowalyszyn, Roberto Pazo-Cid, Michael Schenker, James M. Cleary, Patricio Yañez, Kynan Feeney, Michalis V. Karamouzis, Valerie Poulart, Ming Lei, Hong Xiao, Kaoru Kondo, Mingshun Li, Yelena Y. Janjigian - Nature 2022 被引用: 442
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
著者: Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais, Rafael Díaz, Mark Lakshmanan, Prem Pais, Jeffrey L. Probstfield, Fady T. Botros, Matthew C. Riddle, Lars Rydén, Denis Xavier, Charles Atisso, Leanne Dyal, Stephanie Hall, Rao Ps, G.C. Wong, Álvaro Avezum, Jan Basile, Namsik Chung, Ignacio Conget, William C. Cushman, Edward Franek, Nicolae Hâncu, M Hanefeld, Shaun Holt, Petr Janský, Mátyás Keltai, Fernando Laņas, Lawrence A. Leiter, Patricio López‐Jaramillo, Ernesto Muñoz, Valdis Pīrāgs, Nana Pogosova, Peter Raubenheimer, Jonathan E. Shaw, Wayne Huey‐Herng Sheu, Theodora Temelkova‐Kurktschiev, Mercedes Abella, Andrea Alebuena, Sandra Almagro, Eduardo Amoroso, Paula Anadon, Elizabeth Andreu, Guillermo Aristimuño, Maria Arzadun, María Antonietta Barbieri, Raúl Barcudi, Ines Bartolacci, Gabriel Bolobanich, Anselmo P. Bordonava, Miguel Bustamante Labarta, B. Bustos, Alberto Caccavo, Alejandra Camino, María del Rocío Cantero, Maria Carignano, Luis R Cartasegna, Marcela Cipullo, Víctor Commendatore, Victoria Conosciuto, Osvaldo Costamagna, Claudia A. Crespo, Jose Cuello, Carlos Alberto Cuneo, Sandra Cusimano, Sofia Dean, Claudio Fabián Dituro, Andrea Domínguez, Miguel Farah, Alberto Fernandez, Florencia Fernandez, Adriana Cristina Ferrari, Patricia Flammia, José Antonio Fuentealba, Karina Beatriz Gallardo, C. Perez Garcia, Ruben Garcia Duran, Marcelo Garrido, Rodolfo Gavícola, Claudio Gerbaudo, Graciela Gilli, Ana Paula Giotto, Pedro Godoy Bolzán, Oscar Gómez Vilamajó, Fernando Guerlloy, Cristian Guridi, Narcisa Gutierrez Garrido, Eduardo Hasbani, Sonia Hermida, Miguel Hominal, Adrian D. Hrabar, Adrián Ingaramo, Alejandra Izzicupo, Mario Krynski, Mariana Lagrutta, Paulina Virginia Lanchiotti, Maria Langhe, Veronica Leonard, Javier Llanos, Ricardo López Santi ほか 1,358 名 - The Lancet 2019 被引用: 629
First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 Trial
著者: Yelena Y. Janjigian, Jaffer A. Ajani, Markus Moehler, Lin Shen, Marcelo Garrido, Carlos Gallardo, Lucjan Wyrwicz, Kensei Yamaguchi, James M. Cleary, Elena Elimova, Michalis V. Karamouzis, Ricardo Brugés, Tomasz Skoczylas, Arinilda Campos Bragagnoli, Tianshi Liu, Mustapha Tehfé, Thomas Zander, Rubén Dario Kowalyszyn, Roberto Pazo-Cid, Michael Schenker, Kynan Feeny, Rui Wang, Ming Lei, Clara Chen, Raheel Nathani, Kohei Shitara - Journal of Clinical Oncology 2024 被引用: 216
LBA73 Pathological complete response (pCR) to durvalumab plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in resectable gastric and gastroesophageal junction cancer (GC/GEJC): Interim results of the global, phase III MATTERHORN study
著者: Yelena Y. Janjigian, S-E. Al-Batran, Zev A. Wainberg, Eric Van Cutsem, Daniela Molena, Kei Muro, Woo Jin Hyung, Lucjan Wyrwicz, D-Y. Oh, Takeshi Omori, Markus Moehler, Marcelo Garrido, Sofia Oliveira, Moïshe Liberman, Victor Castro Oliden, Mehmet Bilici, John F. Kurland, Ioannis Xynos, Helen Mann, Josep Tabernero - Annals of Oncology 2023 被引用: 82
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
著者: Sonia S. Anand, Jackie Bosch, John W. Eikelboom, Stuart J. Connolly, Rafael Díaz, Peter Widimsky, Victor Aboyans, Marco Alings, Ajay K. Kakkar, Katalin Keltai, Aldo P. Maggioni, Basil S. Lewis, Stefan Störk, Jun Zhu, Patricio López‐Jaramillo, Martin O’Donnell, Patrick Commerford, Dragoş Vinereanu, Nana Pogosova, Lars Rydén, Keith A.A. Fox, Deepak L. Bhatt, Frank Misselwitz, George Varigos, Thomas Vanassche, Álvaro Avezum, Edmond Chen, Kelley R. Branch, Darryl P. Leong, Shrikant I. Bangdiwala, Robert G. Hart, Salim Yusuf, JORGELINA SALA, Luis R Cartasegna, MARISA VICO, Miguel Hominal, Eduardo Hasbani, Alberto Caccavo, Cesar Javier Zaidman, DANIEL VOGEL, Adrian D. Hrabar, Pablo Schygiel, Carlos Alberto Cuneo, Hugo A Luquez, Ignacio MacKinnon, Rodolfo Andrés Ahuad Guerrero, Juan Pablo Costabel, INES PALMIRA BARTOLACCI, Oscar Montaña, María Antonietta Barbieri, Oscar Gómez Vilamajó, RUBEN OMAR GARCIA DURAN, Lilia Beatriz Schiavi, Marcelo Garrido, ADRIAN INGARAMO, Anselmo P. Bordonava, MARIA JOSE PELAGAGGE, LEONARDO NOVARETTO, JUAN PABLO ALBISU DI GENNERO, LUZ MARIA IBANEZ SAGGIA, MOIRA ALVAREZ, Néstor A. Vita, Stella M. Macı́n, Ricardo D. Dran, Marcelo Cardona, Luis Guzman, RODOLFO JUAN SARJANOVICH, Jesus Cuadrado, SEBASTIAN NANI, MARCOS RAUL LITVAK BRUNO, Carolina Chacón, Laura Maffei, Diego Grinfeld, NATALIA VENSENTINI, CLAUDIO RODOLFO MAJUL, Héctor Luciardi, PATRICIA DEL CARMEN GONZALEZ COLASO, FREDY ANTONI FERRE PACORA, PAUL VAN DEN HEUVEL, Peter Verhamme, Bavo Ector, PHILIPPE DEBONNAIRE, Philippe van de Borne, JEAN LEROY, Herman Schroë, Pascal Vranckx, Ivan Elegeert, E Hoffer, KARL DUJARDIN, CLARISSE INDIO DO BRASIL, Dalton Bertolim Précoma, JOSE ANTONIO ABRANTES, Euler Roberto Fernandes Manenti, Gilmar Reis, José Francisco Kerr Saraiva, Lília Nigro Maia, Mauro Esteves Hernandes, Paulo Roberto Ferreira ROSSI, Fabio Rossi dos Santos, Sérgio Luiz Zimmermann ほか 544 名 - The Lancet 2017 被引用: 880
VP1-2023: Pembrolizumab (pembro) plus chemotherapy (chemo) as first-line therapy for advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) cancer: Phase III KEYNOTE-859 study
著者: Sun Young Rha, L.S. Wyrwicz, P.E. Yanez Weber, Yibing Bai, M.H. Ryu, J. Lee, F. Rivera, G.V. Alves, Marcelo Garrido, K-K. Shiu, M. González Fernández, J. Li, M. Lowery, T. Çil, F.J.S.M. Cruz, S. Qin, L. Yin, S. Bordia, P. Bhagia, D-Y. Oh - Annals of Oncology 2023 被引用: 66
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial
著者: Stuart J. Connolly, John W. Eikelboom, Jackie Bosch, Gilles R. Dagenais, Leanne Dyal, Fernando Laņas, Kaj Metsärinne, Martin O’Donnell, Anthony L Dans, Jong‐Won Ha, Alexander Parkhomenko, Álvaro Avezum, Eva Lonn, Liu Lisheng, Christian Torp‐Pedersen, Petr Widimský, Aldo P. Maggioni, Camilo Félix, Katalin Keltai, Masatsugu Hori, Khalid Yusoff, Tomasz J. Guzik, Deepak L. Bhatt, Kelley R. Branch, Nancy Cook Bruns, Scott D. Berkowitz, Sonia S. Anand, George Varigos, Keith A.A. Fox, Salim Yusuf, JORGELINA SALA, Luis R Cartasegna, MARISA VICO, Miguel Hominal, Eduardo Hasbani, Alberto Caccavo, Cesar Javier Zaidman, DANIEL VOGEL, Adrian D. Hrabar, Pablo Schygiel, Carlos Alberto Cuneo, Hugo A Luquez, Ignacio MacKinnon, Rodolfo Andrés Ahuad Guerrero, Juan Pablo Costabel, INES PALMIRA BARTOLACCI, Oscar Montaña, María Antonietta Barbieri, Oscar Gómez Vilamajó, RUBEN OMAR GARCIA DURAN, Lilia Beatriz Schiavi, Marcelo Garrido, ADRIAN INGARAMO, Anselmo P. Bordonava, MARIA JOSE PELAGAGGE, LEONARDO NOVARETTO, JUAN PABLO ALBISU DI GENNERO, LUZ MARIA IBANEZ SAGGIA, MOIRA ALVAREZ, Néstor A. Vita, Stella M. Macı́n, Ricardo D. Dran, Marcelo Cardona, Luis Guzman, RODOLFO JUAN SARJANOVICH, Jesus Cuadrado, SEBASTIAN NANI, MARCOS RAUL LITVAK BRUNO, Carolina Chacón, Laura Maffei, Diego Grinfeld, NATALIA VENSENTINI, CLAUDIO RODOLFO MAJUL, Héctor Luciardi, PATRICIA DEL CARMEN GONZALEZ COLASO, FREDY ANTONI FERRE PACORA, PAUL VAN DEN HEUVEL, Peter Verhamme, Bavo Ector, PHILIPPE DEBONNAIRE, Philippe van de Borne, JEAN LEROY, Herman Schroë, Pascal Vranckx, Ivan Elegeert, E Hoffer, KARL DUJARDIN, CLARISSE INDIO DO BRASIL, Dalton Bertolim Précoma, JOSE ANTONIO ABRANTES, Euler Roberto Fernandes Manenti, Gilmar Reis, José Francisco Kerr Saraiva, Lília Nigro Maia, Mauro Esteves Hernandes, Paulo Roberto Ferreira ROSSI, Fabio Rossi dos Santos, Sérgio Luiz Zimmermann, RAFAEL RECH, EDUARDO ABIB ほか 542 名 - The Lancet 2017 被引用: 756
Association of Tumor Mutational Burden with Efficacy of Pembrolizumab±Chemotherapy as First-Line Therapy for Gastric Cancer in the Phase III KEYNOTE-062 Study
著者: Keun‐Wook Lee, Eric Van Cutsem, Yung‐Jue Bang, Charles S. Fuchs, Iveta Kudaba, Marcelo Garrido, Hyun Cheol Chung, Jeeyun Lee, Hugo R. Castro, Joseph Chao, Zev A. Wainberg, Z. Alexander Cao, Deepti Aurora-Garg, Julie Kobie, Răzvan Cristescu, Pooja Bhagia, Sukrut Shah, Josep Tabernero, Kohei Shitara, Lucjan Wyrwicz - Clinical Cancer Research 2022 被引用: 88
Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study
著者: Yung‐Jue Bang, Yoon‐Koo Kang, Daniel V.T. Catenacci, Kei Muro, Charles S. Fuchs, Ravit Geva, Hiroki Hara, Talia Golan, Marcelo Garrido, Shadia I. Jalal, Christophe Borg, Toshihiko Doi, Harry H. Yoon, Mary J. Savage, Jiangdian Wang, Rita P. Dalal, Sukrut Shah, Zev A. Wainberg, Hyun Cheol Chung - Gastric Cancer 2019 被引用: 245
Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: Longer Term Follow-Up from the Phase 3 KEYNOTE-240 Trial
著者: Philippe Merle, Masatoshi Kudo, Julien Edeline, Mohamed Bouattour, Ann‐Lii Cheng, Stephen L. Chan, T.W.C. Yau, Marcelo Garrido, Jennifer J. Knox, Bruno Daniele, В. В. Бредер, Ho Yeong Lim, Sadahisa Ogasawara, Stéphane Cattan, Yee Chao, Abby B. Siegel, Iván Martínez‐Forero, Ziwen Wei, Chih-Chin Liu, Richard S. Finn - Liver Cancer 2023 被引用: 46
Efficacy of Pembrolizumab Monotherapy for Advanced Gastric/Gastroesophageal Junction Cancer with Programmed Death Ligand 1 Combined Positive Score ≥10
著者: Zev A. Wainberg, Charles S. Fuchs, Josep Tabernero, Kohei Shitara, Kei Muro, Eric Van Cutsem, Yung‐Jue Bang, Hyun Cheol Chung, Kensei Yamaguchi, Eniko Varga, Jen‐Shi Chen, Daniel Hochhauser, Peter Thuss‐Patience, Salah‐Eddin Al‐Batran, Marcelo Garrido, Uma Kher, Chie‐Schin Shih, Sukrut Shah, Pooja Bhagia, Joseph Chao - Clinical Cancer Research 2021 被引用: 81
Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer
著者: Yelena Y. Janjigian, Salah-Eddin Al-Batran, Zev A. Wainberg, Kei Muro, Daniela Molena, Eric Van Cutsem, Woo Jin Hyung, Lucjan Wyrwicz, Do-Youn Oh, Takeshi Omori, Markus Moehler, Marcelo Garrido, Sulene Cunha Sousa Oliveira, Moïshe Liberman, Victor Castro Oliden, Elizabeth Smyth, Alexander Stein, Mehmet Bilici, Maria Lorena Alvarenga, Vadim Kozlov, Fernando Rivera, Akihito Kawazoe, Olivier Serrano, Eric Heilbron, Alejandra Negro, John F. Kurland, Josep Tabernero - New England Journal of Medicine 2025 被引用: 223
Health-Related Quality of Life With Nivolumab Plus Chemotherapy Versus Chemotherapy in Patients With Advanced Gastric/Gastroesophageal Junction Cancer or Esophageal Adenocarcinoma From CheckMate 649
著者: Markus Moehler, Hong Xiao, Steven I. Blum, Elena Elimova, David Cella, Kohei Shitara, Jaffer A. Ajani, Yelena Y. Janjigian, Marcelo Garrido, Lin Shen, Kensei Yamaguchi, Tianshu Liu, Michael Schenker, Rubén Dario Kowalyszyn, Arinilda Campos Bragagnoli, Ricardo Brugés, Vincenzo Montesarchio, Roberto Pazo-Cid, Shannon Hunter, Eric Davenport, Jinyi Wang, Kaoru Kondo, Mingshun Li, Lucjan Wyrwicz - Journal of Clinical Oncology 2023 被引用: 36
Pathological complete response (pCR) to 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) with or without durvalumab (D) in resectable gastric and gastroesophageal junction cancer (GC/GEJC): Subgroup analysis by region from the phase 3, randomized, double-blind MATTERHORN study.
著者: Yelena Y. Janjigian, Salah‐Eddin Al‐Batran, Zev A. Wainberg, Eric Van Cutsem, Daniela Molena, Kei Muro, Woo Jin Hyung, Lucjan Wyrwicz, Do‐Youn Oh, Takeshi Omori, Markus Moehler, Marcelo Garrido, Sulene CS Oliveira, Moïshe Liberman, Victor Castro Oliden, Mehmet Bilici, John F. Kurland, Ioannis Xynos, Helen Mann, Josep Tabernero - Journal of Clinical Oncology 2024 被引用: 32
Effects of blood pressure and lipid lowering on cognition
著者: Jackie Bosch, Martin O’Donnell, Balakumar Swaminathan, Eva Lonn, Mikul Sharma, Gilles R. Dagenais, Rafael Díaz, Kamlesh Khunti, Basil S. Lewis, Álvaro Avezum, Claes Held, Mátyás Keltai, Christopher M. Reid, William D. Toff, Antonio Dans, Lawrence A. Leiter, Karen Sliwa, Shun Fu Lee, Janice M. Pogue, Robert G. Hart, Salim Yusuf, on behalf of the HOPE-3 Investigators, on behalf of the HOPE-3 Investigators, María Fernanda Alzogaray, Marina Blanco‐Aparicio, Martin Berli, Martina Bevacqua, M. Bustamante Labarta, B. Bustos, Alberto Caccavo, Alfonsina Candiello, Marcelo A. Carignano, Nuria Carrillo, N. Carro, Luis R Cartasegna, W. Casali, Arthur Justi Cassettari, M. Centeno, Juan Pablo Cuello, Carlos Alberto Cuneo, Sandra Cusimano, C. Damonte, M. De Landaluc, Enrico De Martino, Raúl R. Rodrigues-Díez, Antonio Fernández, A. Ferrari, Louis Nuvagah Forti, Marcela Galello, Carlos García, Ruben Garcia Duran, Marcelo Garrido, Federico Giachello, Oscar Gómez Vilamajó, M. González, Fernando Guerlloy, Rodrigo Guerrero, Miguel Hominal, Adrian D. Hrabar, H. Imposti, Paulina Virginia Lanchiotti, Claudia Lauglé, Guillermo E Liniado, Marcos Litvak, Alessandra Longhi, Héctor Luciardi, Ian D.R. Mackinnon, R. Manzano, Julio C. S. Mariño, Barbara Merlo, R. Milesi, C. Mulazzi, Sergio Andrés Nemi, Silvia Ines Orio, MARIA JOSE PELAGAGGE, Sara Raimondi, Louis J. Rodino, Carlos J. Rodríguez, Laura R. Sago, Joan Sala, Anna Sánchez, Ramiro Sánchez, D. Santos, Pablo Schygiel, Virginia Sernia, Thomas W. Smith, Fernando Sökn, Leonardo Soso, Marcelo Trivi, Manuel Vico, Alberto S. Villamil, Dominik J. Vogel, Cesar Javier Zaidman, Walter P. Abhayaratna, J. Canalese, Henry Krum, Anushka Patel, Clarisse K. Brasil, C.B. Alves, Ana Rita Alves ほか 343 名 - Neurology 2019 被引用: 82
Nivolumab (NIVO) plus chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): 3-year follow-up from CheckMate 649.
著者: Yelena Y. Janjigian, Kohei Shitara, Markus Moehler, Marcelo Garrido, Carlos Gallardo, Lin Shen, Kensei Yamaguchi, Lucjan Wyrwicz, Tomasz Skoczylas, Arinilda Silva Campos Bragagnoli, Tianshu Liu, Mustapha Tehfé, Elena Elimova, Ricardo Elías Brugés Maya, James M. Cleary, Michalis V. Karamouzis, Samira Soleymani, Ming Lei, Carlos Amaya‐Chanaga, Jaffer A. Ajani - Journal of Clinical Oncology 2023 被引用: 30